Avoid subcutaneous or intramuscular adrenaline

Alexander, R.E; Pappachan, John; Smith, G. B.; Taylor, Bruce L.

doi:10.1136/bmj.311.7017.1434c

Search citation statements

Order By: Relevance

Paper Sections

Select...

Route Of Administration1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2002

2009

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 7 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…route should be the preferred route for all patients treated by medically trained staff because it avoids the problem of variable absorption after subcutaneous or i.m. administration [39]. There is little evidence on which to base a dose recommendation, but children may respond to boluses as small as 1 mg/kg [31 ].…”

Section: Route Of Administrationmentioning

confidence: 99%

Update on epinephrine (adrenaline) for pediatric emergencies

Walker¹

2009

Current Opinion in Pediatrics

View full text Add to dashboard Cite

Epinephrine is the recommended first-line treatment for anaphylaxis and moderate-to-severe croup. Its role in asthma and bronchiolitis is less clear. Traditional beta2-agonists are seen as first-line therapies for moderate bronchiolitis and asthma exacerbations. Epinephrine may have a role for subsets of patients with both of these illnesses. The preferred route for parenteral treatment is intramuscular. Epinephrine is well tolerated as an adjunct to local anesthesia when used in digital blocks in digits with normal perfusion. Although autoinjectors allow faster access to epinephrine for anaphylaxis, there are many issues surrounding their use and indications.

show abstract

Section: Route Of Administrationmentioning

confidence: 99%